ReviewJournal of translational medicine2024

CVD phenotyping in oncologic disorders: cardio-miRNAs as a potential target to improve individual outcomes in revers cardio-oncology.

Ming Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.